VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 139 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,477,999 | -1.7% | 3,681,747 | +52.4% | 3.83% | -13.7% |
| Q2 2023 | $57,458,940 | +8.3% | 2,415,256 | +15.8% | 4.44% | -11.7% |
| Q1 2023 | $53,060,157 | +3.7% | 2,085,698 | +19.1% | 5.03% | -16.2% |
| Q4 2022 | $51,151,588 | +52.4% | 1,751,167 | +7.0% | 6.00% | +34.2% |
| Q3 2022 | $33,559,000 | +122.0% | 1,636,211 | +25.2% | 4.47% | +48.4% |
| Q2 2022 | $15,117,000 | -34.9% | 1,306,569 | +4.0% | 3.01% | -50.9% |
| Q1 2022 | $23,224,000 | -2.8% | 1,256,051 | +3.9% | 6.14% | -10.0% |
| Q4 2021 | $23,903,000 | – | 1,209,051 | – | 6.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $68,684,566 | 13.41% |
| COMMODORE CAPITAL LP | 2,189,659 | $55,704,925 | 8.48% |
| Fairmount Funds Management LLC | 1,369,623 | $34,843,209 | 5.99% |
| Paradigm Biocapital Advisors LP | 2,085,698 | $53,060,157 | 5.03% |
| Octagon Capital Advisors LP | 1,185,000 | $30,146,400 | 4.34% |
| Logos Global Management LP | 950,000 | $24,168,000 | 3.46% |
| TCG Crossover Management, LLC | 663,610 | $16,882,238 | 3.29% |
| ACUTA CAPITAL PARTNERS, LLC | 168,000 | $4,273,920 | 3.15% |
| Vivo Capital, LLC | 1,678,207 | $42,693,586 | 2.96% |
| TANG CAPITAL MANAGEMENT LLC | 692,925 | $17,628,012 | 2.63% |